AlphaMD and MedSurgPI have entered into a partnership to provide comprehensive Product Development and Commercialization with Medical Affairs Services to clients worldwide.
September 1, 2017
This service is a proprietary process to assist start-ups and established Life Science companies launch their drug, diagnostic and medical device products successfully from concept through launch and post-market surveillance. It encompasses proof-of-concept studies, clinical trial assistance, market research, product development, health economics and outcomes research services, a successful launch, data analytics and pharmacovigilance.
North Carolina Biotechnology Center
Life Sciences Forum 2017 | September 18 | 4:30 pm
Critical Aspects of Regenerative Medicine
Panel includes MedSurgPI's Principal Peter Johnson, M.D.
Article by Gerry L. Klein, M.D. & Maxwell O. Clark appearing in:
The Journal for Clinical Studies | Volume 9, Issue 3 | June 2, 2017
The Pharmacy Adjudicated Clinical Study Supply Process Decreases Risk, Cuts the Cost and Improves the Efficiency when Providing Subjects Unblinded Clinical Study Supplies